PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
40,492,185
Share change
-2,251,786
Total reported value
$65,594,864
Put/Call ratio
25%
Price per share
$1.62
Number of holders
91
Value change
-$3,771,661
Number of buys
44
Number of sells
55

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q2 2024

As of 30 Jun 2024, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,492,185 shares. The largest 10 holders included ORBIMED ADVISORS LLC, ArrowMark Colorado Holdings LLC, Sio Capital Management, LLC, Euclidean Capital LLC, ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, BML Capital Management, LLC, and PFM Health Sciences, LP. This page lists 91 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.